Eudaimonia Asset Management »

Precigen shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Precigen (PGEN) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Precigen

Tip: Access up to 7 years of quarterly data

All positions including Precigen held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Precigen by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 405k 4.18
2025-09-30 $2.2M 677k 3.24

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Precigen

Patient Capital Management
BlackRock
Point72 Asset Management
State Street Corporation
Vanguard Group
Tang Capital Management
Geode Capital Management
Diametric Capital
Iridian Asset Management
Citadel Advisors
Goldman Sachs Group
Driehaus Capital Management
Northern Trust
Charles Schwab Investment Management
Woodline Partners

View all funds holding Precigen